P/E at 65.65 vs Industry's 66.69: What the Data Shows for Apollo Hospitals Enterprise Ltd.

2 hours ago
share
Share Via
Apollo Hospitals Enterprise Ltd continues to demonstrate robust market performance and institutional confidence, underscoring its significance as a key constituent of the Nifty 50 index. With a strong Mojo Score upgrade to 75.0 and a Buy rating, the healthcare giant is poised to maintain its leadership within the hospital sector amid evolving market dynamics.

Valuation Picture: A Slight Discount in a Premium Sector

The hospital sector is characterised by relatively high valuations, with an industry P/E of 66.69 reflecting investor expectations of sustained earnings growth and sector resilience. Apollo Hospitals Enterprise Ltd. trades at a P/E of 65.65, representing a modest discount of approximately 1.5% to the sector average. This valuation positioning suggests that while the stock is priced richly, it is not at a significant premium relative to its peers. The near parity in valuation metrics indicates that the market views the company’s earnings prospects as broadly in line with the sector’s outlook. Apollo Hospitals’s large-cap status, with a market capitalisation of ₹1,28,524.79 crores, further supports its premium valuation compared to smaller hospital players.

Performance Across Timeframes: Consistent Outperformance

Examining the stock’s returns reveals a consistent pattern of outperformance versus the Sensex across all key periods. Over one year, Apollo Hospitals gained 19.98%, contrasting with the Sensex’s 4.68% loss. The three-month return is particularly strong at 17.01%, dwarfing the Sensex’s modest 0.98% gain. Year-to-date, the stock has surged 26.92%, while the benchmark index remains down 8.86%. Even over longer horizons, the stock’s performance is impressive: 67.27% over three years, 121.56% over five years, and a remarkable 557.57% over ten years, all substantially ahead of the Sensex’s respective returns of 17.39%, 47.70%, and 176.87%. This sustained outperformance highlights the company’s ability to deliver shareholder value over multiple market cycles.

However, the short-term momentum shows some moderation. The stock’s one-week gain of 0.66% trails the Sensex’s 1.67%, and it recently ended a three-day consecutive gain streak with a slight fall, despite outperforming the sector by 0.38% on the latest trading day. This divergence raises the question whether the recent pullback signals a pause in momentum or a consolidation phase within a broader uptrend?

Moving Average Configuration: Bullish Across All Key Levels

The technical picture for Apollo Hospitals is notably constructive. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend across both short and long-term horizons. This comprehensive bullish configuration suggests that the recent price action is supported by sustained buying interest and that the stock is in a confirmed uptrend rather than a transient rally. Such alignment of moving averages is often interpreted as a sign of technical strength, reinforcing the positive momentum observed in the performance data.

Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!

  • - Sustainable profitability reached
  • - Post-turnaround strength
  • - Comeback story unfolding

Be Early to the Comeback →

Sector Context: Hospital Industry Performance

The hospital sector has experienced mixed results recently, with a combination of positive, flat, and negative performances among constituent stocks. Despite this variability, Apollo Hospitals stands out as a consistent outperformer. Its ability to maintain a valuation close to the sector average while delivering superior returns suggests operational resilience and effective management execution. The sector’s average P/E of 66.69 reflects elevated expectations, and Apollo Hospitals’s near-parity valuation indicates that the market views it as a core player within this competitive landscape.

Rating Context: Previously Rated Hold, Now Reassessed

On 11 May 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from a previous Hold rating by MarketsMOJO. This reassessment reflects the evolving data profile, including strong multi-year returns, a solid technical setup, and valuation metrics aligned with the sector. The rating change invites investors to consider what is the current rating? and how it integrates these multiple dimensions of analysis.

Collective Data Insights: A Balanced Yet Bullish Profile

Bringing together valuation, performance, technical, and sector data, Apollo Hospitals Enterprise Ltd. presents a compelling profile. Its P/E ratio is closely aligned with the hospital industry average, suggesting fair pricing relative to peers. The stock’s consistent outperformance across short, medium, and long-term horizons, combined with a bullish moving average configuration, indicates sustained strength. While recent short-term gains have moderated slightly, the overall trend remains positive. The sector’s mixed performance further highlights Apollo Hospitals’s relative resilience. Investors may wish to explore should investors in Apollo Hospitals hold, buy more, or reconsider?

Thinking about Apollo Hospitals Enterprise Ltd.? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this large-cap stock!

  • - Real-time Verdict available
  • - Financial health breakdown
  • - Fair valuation calculated

Check the Verdict Now →

Summary

In summary, Apollo Hospitals Enterprise Ltd. trades at a valuation closely mirroring its sector peers, with a P/E of 65.65 against the industry’s 66.69. Its performance over one year and beyond has been markedly superior to the Sensex, supported by a strong technical setup with the stock trading above all major moving averages. The hospital sector’s mixed results underscore the company’s relative strength. The recent rating reassessment from Hold reflects these data points, inviting investors to consider the implications carefully. The stock’s near 52-week high proximity of 0.87% further emphasises its current strength in the market.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News